This is a cooperative agreement (UG3/UH3) from the NIDCR for planning and implementing clinical trials involving drugs, biologics, devices, and/or procedures. The funding opportunity is PAR-25-057 (CFDA: 93.121).
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.